(Reuters) – Masimo Corp on Monday reported preliminary second-quarter results below analysts’ estimates, sending the medical device maker’s shares down about 20% in after-market trading.
The company forecast consolidated revenue for the second quarter between $453 million and $457 million, compared with estimates of $553.2 mln, according to Refinitiv.
(Reporting by Savyata Mishra in Bengaluru; Editing by Shounak Dasgupta)
